Medicine
Giapreza 0.5 mg/1 mL injection
Giapreza 0.5 mg/1 mL injection is a prescription medicine containing Angiotensin ii for intravenous use, marketed by La Jolla Pharmaceutical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
GIAPREZA vials should be stored in the refrigerator between 2°C to 8°C (36°F…
Key facts
- Active ingredient (INN)
- Angiotensin ii
- Brand
- Giapreza
- Strength
- 0.5 mg/1 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 1 mL
- Marketing authorisation holder
- La Jolla Pharmaceutical
- Manufacturer
- La Jolla Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- GIAPREZA vials should be stored in the refrigerator between 2°C to 8°C (36°F to 46°F). Discard prepared diluted solution after 24 hours at room temperature or under refrigeration.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01CX09 Angiotensin ii
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 September 2022
- Identifiers
- RxCUI 1999007, 1999012, 2611704 +1DailyMed set ID c265d69a-3efe-4107-9a9e-e6fd3d531c48NDC 68547-005Application NDA209360
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 68547-005-01 | La Jolla Pharmaceutical | 15 September 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Angiotensin ii
Clinical summary
Angiotensin ii is a vasoconstrictor. It is available as injection for intravenous use. MedsAcross supplies Angiotensin ii for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Angiotensin iiFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Giapreza prescribing information (La Jolla Pharmaceutical) · U.S. National Library of Medicine, DailyMed
- Giapreza: European public assessment report (EPAR) · European Medicines Agency
Need Giapreza 0.5 mg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.